Le Lézard
Classified in: Health
Subject: MRR

Metagenomics Market to Reach $6.71 Billion by 2031, Growing at a CAGR of 15.6% from 2024 -- Exclusive Report by Meticulous Research®


Market Growth Driven by Advancements in Sequencing Technologies and Expanding Applications in Microbiome Research

REDDING, Calif., March 28, 2025 /PRNewswire/ -- According to a new market research report titled 'Metagenomics Market Size, Share, Forecast, & Trends Analysis by Technology (Shotgun Sequencing, 16S rRNA Sequencing, Whole Genome Sequencing), Product (Kits & Reagents, Sequencing Services, Bioinformatics Tools), Application (Clinical Diagnostics, Environmental Monitoring, Drug Discovery, Agriculture) ? Global Forecast to 2032', published by Meticulous Research®, the metagenomics market is projected to reach $6.71 Billion by 2031, growing at a CAGR of 15.6% from 2024 to 2031.

Meticulous_Research_Logo_1

Key Market Drivers and Trends

The metagenomics market is witnessing robust growth due to the rising adoption of next-generation sequencing (NGS) technologies in microbiome research, disease diagnostics, and environmental monitoring. The ability of metagenomic sequencing to analyze complex microbial communities without the need for culturing is revolutionizing pathogen detection, antibiotic resistance studies, and precision medicine.

Increasing investments in microbiome-based therapeutics, government initiatives supporting genomic research, and the expanding application of metagenomics in agriculture and wastewater treatment are further propelling market expansion. Moreover, AI-driven bioinformatics tools are enhancing data analysis efficiency, enabling faster and more accurate microbial profiling.

For more comprehensive insights, download the FREE report sample of the metagenomics market: https://www.meticulousresearch.com/download-sample-report/cp_id=6127

Growth Opportunities

Emerging economies in Asia-Pacific and Latin America present substantial growth opportunities due to increasing investments in genomic research, expanding healthcare infrastructure, and rising awareness of microbiome-based diagnostics. Advances in portable sequencing technologies and cloud-based bioinformatics platforms are making metagenomics more accessible, fostering its adoption in remote and resource-limited settings.

Market Challenges

Despite strong growth potential, challenges such as high sequencing costs, complex data interpretation, and the need for standardized analytical pipelines hinder the widespread adoption of metagenomics. Regulatory concerns related to genomic data privacy and bioethical considerations also pose hurdles for market expansion, particularly in clinical applications.

Get Insightful Data on Regions, Market Segments, Customer Landscape, and Top Companies (Charts, Tables, Figures and More) - https://www.meticulousresearch.com/product/metagenomics-market-6127

Segment Insights

By Technology: Shotgun sequencing dominates the market due to its comprehensive microbial diversity analysis capabilities, while 16S rRNA sequencing remains a preferred choice for taxonomic classification in environmental and clinical research.

By Product: Kits & reagents account for the largest market share, driven by increasing demand for high-throughput sequencing workflows. Bioinformatics tools and services are gaining traction, supporting complex data interpretation and predictive modeling.

By Application: Clinical diagnostics is the fastest-growing segment, with metagenomics playing a crucial role in infectious disease detection, antimicrobial resistance monitoring, and oncology. Environmental monitoring and agricultural applications are also expanding, with metagenomic sequencing aiding in soil health assessment, pollution control, and sustainable farming practices.

Request a customized research analysis tailored to your specific requirements: https://www.meticulousresearch.com/request-customization/cp_id=6127

Geographic Market Insights

North America leads the global metagenomics market, supported by strong research funding, government genomics initiatives, and the presence of key industry players. The Asia-Pacific region is projected to grow at the highest CAGR, driven by increasing investments in biotechnology, rising healthcare expenditures, and growing collaborations between academic institutions and industry players.

Competitive Landscape

The metagenomics market is highly competitive, with key players focusing on technological advancements, strategic partnerships, and geographic expansion. Leading companies such as Illumina, Thermo Fisher Scientific, Qiagen, Oxford Nanopore Technologies, and BGI Group are investing heavily in R&D to enhance sequencing accuracy, reduce turnaround times, and develop cost-effective bioinformatics solutions.

Collaborations between sequencing technology providers and pharmaceutical companies are driving innovations in microbiome-based drug development and precision medicine. Additionally, startups specializing in AI-powered microbial analytics and cloud-based sequencing services are emerging as key disruptors in the market.

Sustainability initiatives, such as eco-friendly sample processing techniques and reusable sequencing platforms, are also gaining momentum as companies strive to minimize environmental impact while expanding market reach.

Immediate Delivery Available | Buy this Research Report (Insights, Charts, Tables, Figures and More)- https://www.meticulousresearch.com/view-pricing/1444

Scope of the Report:

Metagenomics Market, by Offering

Metagenomics, by Technology

(Note: Other technologies include targeted microbial sequencing, meta transcriptome sequencing, and pyrosequencing.)

Metagenomics, by Application

(Note: Other applications include food & nutrition, agriculture & soil health, marine microbiomes, and extremophiles.)

Metagenomics Market, by Geography

North America (U.S., Canada), Europe (Germany, U.K., France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Australia, Rest of APAC), Latin America, and the Middle East & Africa

Related Reports:

Next-Generation Sequencing (NGS) Market: Industry Outlook by Offering (Sample Preparation [DNA Extraction, Library Preparation, Automation], Systems, Bioinformatics, Sequencing Services) Application (Clinical, Research) End User ? Global Forecast to 2031

https://www.meticulousresearch.com/product/NGS-market-industry-outlook-5957

NGS Library Preparation Market by Product (Kits, Reagents, Instruments), Sequencing Type (Genome, Exome, Targeted), Application (Diagnostics, Discovery), End User (Hospitals, Diagnostic Laboratories, Pharmaceutical, Academic) ? Global Forecast to 2030

https://www.meticulousresearch.com/product/ngs-library-preparation-market-5319

Genetic Testing Market by Offering (Consumables, Reagents, Instruments, Services), Test Type (Diagnostic, Prenatal, Carrier, Newborn, Preimplantation), Method (Molecular, Chromosomal), End User (Hospitals, Diagnostic Laboratories) - Global Forecast to 2030

https://www.meticulousresearch.com/product/genetic-testing-market-5370

Bioinformatics Market Size, Share, Forecast, & Trends Analysis By Solutions & Services (Knowledge Management, Sequence Analysis, Data Analysis) Application (Genomics, Metabolomics, Transcriptomics) Industry (Health, Agriculture) ? Global Forecast to 2031

https://www.meticulousresearch.com/product/bioinformatics-market-5731

About Meticulous Research

We are a trusted research partner for leading businesses worldwide, empowering Fortune 500 organizations and emerging enterprises with market intelligence designed to drive revenue transformation and strategic growth. Our insights reveal future growth opportunities, equipping clients with a competitive edge through a versatile suite of research solutions?including syndicated reports, custom research, and direct analyst engagement. Each year, we conduct over 300 syndicated studies and manage 60+ consulting engagements across eight major sectors and 20+ geographic markets, all to deliver targeted business insights that help our clients lead in a rapidly evolving global market.

With a strong focus on problem-solving for complex business challenges, our research enables organizations to navigate change with assertion, aligning it with strategic pathways for sustainable growth. By identifying innovative and effective solutions, we empower leaders to make impactful decisions that drive operational excellence and fuel innovation. We are committed to crafting insights that enhance business performance and help our clients unlock new revenue opportunities, positioning them for long-term success in the competitive global marketplace.

Contact:

Meticulous Market Research Pvt. Ltd.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe: +44-203-868-8738
APAC: +91 744-7780008
Email- [email protected]
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Top Market Research Reports Blog - https://meticulousblog.org/ 

Content Source: https://www.meticulousresearch.com/pressrelease/1365/metagenomics-market

Logo: https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg


These press releases may also interest you

at 06:13
Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced its financial results for the year ended...

at 06:05
Urethral stricture affecting men of all ages, with increasing incidence after 55, is a recurring problem despite several treatment options. By transplanting autologous lab-engineered buccal tissue cells (BEES-HAUS), Dr Akio Horiguchi successfully...

at 06:05
BeiGene, Ltd. , a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency issued a positive opinion recommending...

at 06:05
QIAGEN N.V. announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2024, with the U.S. Securities and Exchange Commission. The document can be...

at 06:05
Exact Sciences Corp. , a leading provider of cancer screening and diagnostic tests, today announced the launch of Cologuard Plustm, the most accurate noninvasive colorectal cancer screening (CRC) test reported in studies to date.* FDA-approved for...

at 06:05
Novo Nordisk presented new data from the retrospective, observational SCORE study that assessed treatment with semaglutide 2.4 mg and the risk of major adverse cardiovascular events (MACE) in adults with overweight or obesity and established...



News published on and distributed by: